PIPELINE EMBOLIZATION DEVICE
Report
- Report Number
- 2029214-2014-00409
- Event Type
- Death
- Date Received
- July 17, 2014
- Report Date
- June 17, 2014
- Manufacturer
- EV3 NEUROVASCULAR
- Product Code
- OUT
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER
Narratives
THE DEVICE INVOLVED IN THE EVENT WILL NOT BE RETURNED FOR EVALUATION AS IT WAS IMPLANTED IN THE PATIENT. (B)(4).
INFORMATION RECEIVED FROM THE ARTICLE: MONTEITH SJ, M.D., TSIMPAS A, M.D., M.SC., DUMONT AS, MD., ET AL. ENDOVASCULAR TREATMENT OF FUSIFORM CEREBRAL ANEURYSMS WITH THE PIPELINE EMBOLIZATION DEVICE. J NEUROSURG 120. 2014:945-954. A TOTAL OF 146 PATIENT WERE TREATED WITH PIPELINE EMBOLIZATION DEVICE (PED). 24 OF THE 144 WERE IDENTIFIED AS HAVING FUSIFORM ANEURYSMS (9 MEN AND 15 WOMEN) WITH A MEAN AGE OF 59 YEARS. ALL THE PATIENTS WERE GIVEN ANTI-PLATELET THERAPY. 23 OF THE 24 HAD NO PROCEDURAL COMPLICATIONS. ONE HAD A GROIN PSEUDOANEURYSM THAT WAS MANAGED CONSERVATIVELY. 4 OF THE 24 HAD MAJOR COMPLICATIONS RELATED TO THE ANEURYSM TREATMENT AND THERE WAS ONE DEATH. CASE (B)(4): TREATMENT OF A LARGE ANEURYSM MEASURING 22MM X 23MM X 20MM LOCATED IN THE BASILAR TRUNK. THE PATIENT PRESENTED WITH ATAXIA AND CRANIAL NERVE PALSY VI UNDERWENT PIPELINE (5MM X 30MM) EMBOLIZATION TREATMENT INVOLVING ONE PIPELINE WITHOUT ISSUES. THE PATIENT HAD A VP SHUNT PLACED IN PREPARATION FOR THE PREDICTED SWELLING AND AQUEDUCTAL CLOSURE RESULTING FROM THE ANEURYSM THROMBOSIS. THE PATIENT DID WELL. 7 MONTHS POST PROCEDURE, THE PATIENT SUFFERED A SUBARACHNOID HEMORRHAGE AND CARE WAS WITHDRAWN BY THE FAMILY AND HE SUBSEQUENTLY EXPIRED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 420150 | PIPELINE EMBOLIZATION DEVICE | FLOW DIVERSION | OUT | EV3 NEUROVASCULAR | FA-71500-30 | NOT REPORTED |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 77 YR | Death |